Navigation Links
Caliper Life Sciences Expands Offering for Next Generation Sequencing Workflows
Date:10/21/2010

HOPKINTON, Mass., Oct. 21 /PRNewswire/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced the availability of a new, higher sensitivity DNA assay for its LabChip GX analytical platform, as well as the new Sciclone NGS Workstation. The LabChip GX assay is optimized for QC steps that assess concentration and size distribution of next generation sequencing (NGS) libraries. The Sciclone NGS Workstation automates the most commonly used NGS sample preparation steps, including adapter ligation, exome capture, PCR setup, and nucleic acid cleanup, and other enzymatic steps.

In addition to the LabChip GX and Sciclone NGS workstation, Caliper has recently commercially launched the LabChip XT for fast, accurate size selection of sheared libraries. These NGS sample preparation platforms are experiencing rapid adoption, with recent purchases by the Broad Institute, BGI, Joint Genomes Institute, National Center for Genome Resources, BioReference Laboratories, Sequenom, University of Miami, and many other sequencing institutions.

"Caliper continues to make strategic investments, guided by our collaborators at leading sequencing centers, to develop sample preparation solutions for NGS workflows," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "Caliper's presence in the NGS market is rapidly expanding. Our sales backlog for the LabChip XT is very healthy and we are seeing broad adoption of Caliper's platforms in this market."

The LabChip GX utilizes Caliper's innovative microfluidics technology to perform reproducible, high-resolution, electrophoretic separations for analyzing DNA or RNA integrity. The Sciclone NGS Workstation is Caliper's automated liquid handling workstation, which is a robust, scalable platform that has been specifically customized for NGS methods and can be integrated with the LabChip GX platform for extended hands-off automation. The LabChip XT removes a key bottleneck in sequencing library preparation by replacing tedious and inconsistent gel isolation steps. For additional information about Caliper's solutions for next generation sequencing, please visit www.caliperls.com/genomics.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper, LabChip, and Sciclone are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences Third Quarter 2010 Financial Results Conference Call Notice
2. Caliper Settles Outstanding Litigation with Shimadzu
3. Caliper Life Sciences and Stanford University File a Patent Infringement Lawsuit Against Carestream Health, Inc.
4. Caliper Life Sciences Fourth Quarter 2009 Financial Results Conference Call Notice
5. Caliper Life Sciences Forms Scientific Advisory Board for Next Generation Sequencing
6. Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
7. Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic
8. Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research
9. Caliper Awarded New Task Order for EPA ToxCast Program
10. Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
11. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 9, 2016 Research and Markets has ... report to their offering. ... The report forecasts the global optical transceiver market ... The report covers the present scenario and the ... calculate the market size, the report considers the revenue generated from ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company ... severe, rare diseases, today announced that senior management will participate in ... Conference at the InterContinental Barclay Hotel in New York ... ET. About aTyr Pharma ... aTyr Pharma is engaged in the ...
(Date:12/9/2016)... Bermuda , Dec. 9, 2016  Axovant ... leading clinical-stage biopharmaceutical company focused on the treatment ... the data from a Phase 2b trial evaluating ... care donepezil, compared with donepezil plus placebo in ... that the addition of intepirdine to treatment was ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... , ... "I have gout, and I wanted to treat it naturally," said ... to relieve gout and pain caused by varicose veins. I drank it every morning ... relieved what VA doctors called the worst sinusitis case they'd seen and relieved gas, ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric ... patient safety. Only a few hospitals and facilities have earned this distinction. This ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the ... and Eric Hoessel to vice president of sales. , Litsinger joined Mirixa ...
(Date:12/8/2016)... ... 08, 2016 , ... SunView Software aims to redefine IT ... both engaging and easy to use. Coming off the heels of a successful ... its plans to roll out new AI-powered self-service enhancements to help organizations implement ...
Breaking Medicine News(10 mins):